Evidence map›Paper›PMID 36013521›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis.

Fabrizio Gozzi, Lucia Belloni, Raffaella Aldigeri, Pietro Gentile, Valentina Mastrofilippo, Luca De Simone, Elena Bolletta, Federica Alessandrello, Martina Bonacini, Stefania Croci and 4 more

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Fabrizio GozziOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-4147-5534
Lucia BelloniClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Raffaella AldigeriDepartment of Medicine and Surgery, University of Parma, 43100 Parma, Italy.
Pietro GentileDepartment of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0002-5485-5237
Valentina MastrofilippoOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Luca De SimoneOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0003-1471-1914
Elena BollettaOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0003-0292-0153
Federica AlessandrelloDepartment of Biomedical Sciences, Ophthalmology Clinic, University Hospital of Messina, 98125 Messina, Italy.
Martina BonaciniClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-6830-6781
Stefania CrociClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0002-8622-0439
Alessandro ZerbiniClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.
Gian Maria CavalliniDepartment of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Carlo SalvaraniDepartment of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Luca CiminoOcular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy.ORCID 0000-0001-7956-9950
Istituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Modena and Reggio Emilia · ITUniversity of Cagliari · ITUniversity of Messina · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: A cross-sectional single-center study was conducted to investigate the etiology in hypertensive anterior uveitis whose clinical features are not fully distinctive from cytomegalovirus or from rubella virus and to demonstrate the possible coexistence of both these viruses in causing anterior uveitis. Materials and Methods: The clinical charts of a cohort of patients with hypertensive viral anterior uveitis of uncertain origin consecutively seen in a single center from 2019 to 2022 were retrospectively reviewed; data on the clinical features, aqueous polymerase chain reaction, and antibody response to cytomegalovirus and rubella virus were collected. Results: Forty-three eyes of as many subjects with viral anterior uveitis of uncertain origin were included. Thirty-two patients had an aqueous polymerase chain reaction or antibody index positive to cytomegalovirus only, while 11 cases had an aqueous antibody response to both cytomegalovirus and rubella virus. This latter overlapping group had a statistically significant higher rate of hypochromia and anterior vitritis (p-value: 0.02 and < 0.001, respectively). Conclusions: The simultaneous presence of intraocular antibodies against cytomegalovirus and rubella virus could redefine the differential diagnosis of hypertensive viral anterior uveitis, demonstrating a possible “converged” immune pathway consisting in a variety of stimuli.

Indexed as

Eye Infections, ViralUveitis, AnteriorAqueous HumorCross-Sectional StudiesCytomegalovirusDNA, ViralHumansRetrospective StudiesRubella virusDNA, Viralantibody indexcytomegalovirusFuchs Uveitisoverlapping viral anterior uveitisrubella virus

Identifiers

PMID36013521
PMCPMC9413047
OpenAlexW4289940220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.